After terminating a non binding letter of intent for a potential merger with QumulusAI, Vincerx Pharma will wind down, the company announced April 8. The San Mateo, California–based biotech, whose pipeline focused on addressing unmet medical needs for cancer patients, is also exploring monetization of assets and outlicensing opportunities.